Interleukin-1 receptor antagonist treatment in acute ischaemic stroke does not alter systemic markers of anti-microbial defence. (2019)
Attributed to:
TREM-2, inflammation resolution and the transition from brain injury to repair after stroke
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.12688/f1000research.19308.2
PubMed Identifier: 31700615
Publication URI: http://europepmc.org/abstract/MED/31700615
Type: Journal Article/Review
Volume: 8
Parent Publication: F1000Research
ISSN: 2046-1402